Meta tags:
description=Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.;

Headings (most frequently used words):

clinical, and, to, therapeutics, announces, with, first, of, partners, forhealthcare, our, funds, muna, ceo, transition, as, pipeline, advances, partnership, french, cancer, research, network, ffcd, expands, bioptimus, stela, programme, moon, surgical, uncovr, announce, 20, cases, automated, operative, reporting, on, maestro, health, is, wealth, why, europe, must, act, now, strengthen, its, life, sciences, industry, mediar, cohorts, dosed, in, phase, trial, mtx, 439, for, fibrosis, associated, chronic, kidney, disease, ckd, additions, advisory, board, tissium, secures, 60, million, support, commercial, activities, platform, expansion,

Text of the page (most frequently used words):
sofinnova (22), and (22), the (15), partners (13), our (11), for (10), stage (9), strategy (8), 2026 (7), with (7), june (6), early (6), companies (6), #clinical (5), that (5), biotech (5), start (5), medtech (5), has (4), contact (3), first (3), life (3), managing (3), partner (3), they (3), have (3), patients (3), ups (3), digital (3), medicine (3), industrial (3), people (3), submit (3), project (3), esg (2), legal (2), terms (2), regulatory (2), information (2), privacy (2), policy (2), therapeutics (2), announces (2), health (2), europe (2), its (2), sciences (2), partnership (2), research (2), news (2), well (2), entrepreneurs (2), treat (2), each (2), but (2), this (2), ultimately (2), later (2), believe (2), you (2), company (2), being (2), are (2), strategies (2), under (2), management (2), backed (2), 500 (2), years (2), experience (2), 1972 (2), biovelocita (2), accelerator (2), leading (2), build (2), telethon (2), investments (2), science (2), around (2), world (2), invests (2), across (2), agriculture (2), crossover (2), technologies (2), creating (2), capital (2), investing (2), biopharma (2), focus (2), healthcare (2), funds (2), ability (2), potential (2), team (2), over (2), better (2), future (2), planet (2), linkedin, tissium, secures, million, support, commercial, activities, platform, expansion, mediar, cohorts, dosed, phase, trial, mtx, 439, fibrosis, associated, chronic, kidney, disease, ckd, additions, advisory, board, wealth, why, must, act, now, strengthen, industry, moon, surgical, uncovr, announce, cases, automated, operative, reporting, maestro, french, cancer, network, ffcd, expands, bioptimus, stela, programme, muna, ceo, transition, pipeline, advances, latest, henrijette, richter, chairman, antoine, papiernik, graziano, seghezzi, knows, everyone, other, loyal, strong, very, see, easy, brand, fantastic, all, because, joined, return, financial, into, translates, product, bring, whether, backing, investors, good, going, lives, save, consistent, remained, evolved, know, what, continue, creators, known, investment, euros, assets, established, partnering, organizations, create, european, backs, techbio, healthtech, intersection, biology, data, computation, makes, italian, benefit, sustainable, chemicals, food, materials, sectors, growth, clinically, validated, their, preparing, commercialization, house, focused, launching, through, hands, building, flagship, fund, founding, lead, investor, developing, groundbreaking, therapeutic, active, entire, value, chain, from, seed, sustainability, manifestation, recognize, opportunity, unlock, dedicated, tailored, strategic, approach, cornerstone, identity, lasting, relationships, trust, transparency, invest, who, strive, transform, processes, cutting, edge, will, contribute, founded, more, than, market, leaders, globe, today, billion, breakthrough, innovations, solve, most, pressing, problems, agility, diverse, points, view, fuel, thrive, complex, environment, results, portfolio, about,

Text of the page (random words):
partners for sofinnova partners submit a project submit a project submit a project contact us privacy policy regulatory information legal terms esg about strategies team portfolio news 0 results partners for healthcare we believe in a better future for people and the planet we re investing in a better future for people and the planet at sofinnova partners we focus on breakthrough innovations that have the potential to solve the world s most pressing problems experience agility and diverse points of view fuel our ability to thrive in a complex environment founded in 1972 sofinnova partners has backed more than 500 companies over 50 years creating market leaders around the globe today sofinnova partners has over 4 billion under management partners for life is a cornerstone of our identity we build lasting relationships with trust and transparency we invest in entrepreneurs who strive to transform biopharma medtech digital medicine agriculture and industrial processes with cutting edge science that will contribute to people s health and well being our funds sofinnova partners is active across the entire value chain of life sciences investments from seed to later stage with a focus on healthcare and sustainability each of our funds is a manifestation of our ability to recognize opportunity and unlock its potential with a dedicated team and a tailored strategic approach sofinnova capital the sofinnova capital strategy is our flagship fund investing as founding or lead investor in early stage biopharma and medtech start ups developing groundbreaking therapeutic technologies sofinnova md start the sofinnova md start strategy is our in house medtech accelerator focused on creating and launching early stage medtech companies through hands on company building sofinnova crossover the sofinnova crossover strategy invests in growth stage biotech and medtech companies that have clinically validated their technologies and are preparing for commercialization sofinnova industrial biotech our industrial biotech strategy invests in early stage sustainable companies across the agriculture chemicals food and materials sectors sofinnova telethon the sofinnova telethon strategy makes early stage investments in leading italian science for the benefit of patients around the world sofinnova digital medicine our digital medicine strategy backs early stage techbio and healthtech start ups at the intersection of biology data and computation sofinnova biovelocita the sofinnova biovelocita strategy is our biotech accelerator partnering with leading research organizations to create and build european biotech start ups 1972 established 50 years of experience 500 companies backed 4 bn euros in assets under management 7 investment strategies we are known for being company creators we continue to do what we know our strategy has evolved but has remained consistent if you treat patients you save lives ultimately this is going to be good for investors we believe that by backing companies whether early stage or later stage that bring a product to patients ultimately this translates into financial return i joined sofinnova partners because first of all they have a fantastic brand in europe but it s easy to see it is a very strong partnership they re loyal to each other and everyone knows they treat entrepreneurs well graziano seghezzi managing partner sofinnova partners antoine papiernik chairman managing partner sofinnova partners henrijette richter managing partner sofinnova partners latest news 30 june 2026 muna therapeutics announces ceo transition as clinical pipeline advances 30 june 2026 partnership with french cancer research network ffcd expands bioptimus s stela programme 30 june 2026 moon surgical and uncovr announce first 20 clinical cases of automated operative reporting on maestro 29 june 2026 health is wealth why europe must act now to strengthen its life sciences industry 24 june 2026 mediar therapeutics announces first cohorts dosed in phase 1 clinical trial of mtx 439 for fibrosis associated with chronic kidney disease ckd and additions to clinical advisory board 24 june 2026 tissium secures 60 million to support commercial and clinical activities and platform expansion contact us contact us privacy policy regulatory information legal terms esg 2026 sofinnova partners linkedin